Xometry XMTR 深 沪
等待开盘 08-25 09:30:00 美东时间
84.23
+0.640
+0.77%
华盛通- 最 高86.225
- 今 开84.73
- 成交量 27.08万股
- 最 低 82.53
- 昨 收 83.59
- 总市值 48.28亿
- 52周最高 106.08
- 市盈率 静 --
- 换手率 0.47%
- 52周最低 35.86
- 委 比 76.47%
- 总股本 5732.36万
- 历史最高 106.08
- 量 比 0.65
- 振 幅 4.42%
- 历史最低 11.08
- 每 手 1
- 风险率 18.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JPMorgan's Top Consumer Tech Picks: 5 Stocks It Likes Right Now
Shopify Inc. (NASDAQ:SHOP) and Take-Two Interactive Software Inc. (NASDAQ:TTWO) remain JPMorgan’s highest-conviction consumer technology investments, but the New York-based bank says investors shouldn’t overlook a handful of smaller companies benefiting from long-term trends including artificial int...
08-24 21:18
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Rosenblatt Initiates Coverage On Xometry with Buy Rating, Announces Price Target of $110
Rosenblatt analyst Scott Devitt initiates coverage on Xometry (NASDAQ:XMTR) with a Buy rating and announces Price Target of $110.
08-20 21:28
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Cantor Fitzgerald Maintains Overweight on Xometry, Raises Price Target to $110
Cantor Fitzgerald analyst Troy Jensen maintains Xometry (NASDAQ:XMTR) with a Overweight and raises the price target from $85 to $110.
08-05 21:00
财报速睇 | Xometry 2026财年Q2营收2.29亿美元，同比增长40.5%；归母净利润亏损0.05亿美元，同比亏损缩窄80.8%
华盛资讯8月5日讯，Xometry公布2026财年Q2业绩，公司Q2营收2.29亿美元，同比增长40.5%，归母净利润亏损0.05亿美元，同比亏损缩窄80.8%。
08-05 09:18
Xometry 2026年第二季度财报：营收增长41%，亏损收窄
Xometry 2026年第二季度营收2.293亿美元，同比增长41%，GAAP每股亏损收窄至0.10美元，调整后EBITDA升至1,414万美元；Marketplace增长45%，全年营收增长指引上调至33%至34%。
08-05 06:53
Xometry shares are trading higher after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates.
Xometry shares are trading higher after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates.
08-04 20:29
财报速睇 | Xometry 2026财年Q2营收2.29亿美元，同比增长40.5%；归母净利润亏损0.05亿美元，同比亏损缩窄80.8%
华盛资讯8月4日讯，Xometry公布2026财年Q2业绩，公司Q2营收2.29亿美元，同比增长40.5%，归母净利润亏损0.05亿美元，同比亏损缩窄80.8%。
08-04 19:34
Xometry Sees Q3 Sales $234.000M-$236.000M vs $221.633M Est
Xometry (NASDAQ:XMTR) sees Q3 sales of $234.000 million-$236.000 million vs $221.633 million analyst estimate.
08-04 19:09
